BMO Capital analyst Gary Nachman lowered the price target on Optinose (NASDAQ: OPTN) to $5.00 (from $6.00) while maintaining an ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE